
|Articles|December 16, 2008
Sol-Gel unveils new research facilities
Ness Ziona, Israel - Sol-Gel Technologies unveiled a new plant with state-of-the-art facilities for the development of topical dermatology drugs, according to a press release.
Advertisement
Ness Ziona, Israel
- Sol-Gel Technologies unveiled a new plant with state-of-the-art facilities for the development of topical dermatology drugs, according to a press release.
The new plant houses research, development and analytical laboratories, pilot production facilities and management offices, according to the company.
Sol-Gel is working to develop a new anti-acne kit.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
UCB Presents 3-Year BE HEARD Trial Results for Bimekizumab in Moderate-to-Severe HS
3
World Cancer Day 2026: La Roche-Posay and ONS Partner to Launch Skin of Color Toxicity Repository
4
Sagimet and Ascletis Report Positive 52-Week Safety and Efficacy Data for Denifanstat in Acne
5











